Latest Tetrahydrobiopterin Stories
Approval delivers first pharmaceutical therapy for children and adults with ultra-rare, life-limiting disorder TORONTO, July 7, 2014 /CNW/ - BioMarin Pharmaceutical Inc.
- Canadian PKU and Allied Disorders encourages governments to fund PKU treatment tools as outlined by guidelines to improve outcomes in 2,000 Phenylketonuria patients - TORONTO,
PKU uncle will cycle across Canada in 71 days this summer to raise awareness and $25,000 TORONTO, Jan.
- To swell, as grain or wood with water.